Article
The impact of HIV-1 subtype on the clinical response on HAART.
Journal of HIV therapy - 1 Nov 2002
Frater John
Abstract excerpt
Highly active antiretroviral therapy (HAART) has led to a reduction in HIV-related mortality and morbidity. Most patients who have benefited from HAART are infected with HIV-1 subtype B, which predominates in Western Europe, the USA and the rest of the industrialised world. However, most HIV-infe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
